A

ABL Bio Inc
KOSDAQ:298380

Watchlist Manager
ABL Bio Inc
KOSDAQ:298380
Watchlist
Price: 27 400 KRW 3.79% Market Closed
Market Cap: 1.3T KRW
Have any thoughts about
ABL Bio Inc?
Write Note

ABL Bio Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ABL Bio Inc
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
A
ABL Bio Inc
KOSDAQ:298380
Depreciation & Amortization
-â‚©1.9B
CAGR 3-Years
0%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Depreciation & Amortization
-â‚©162.9B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Bioscience Co Ltd
KRX:302440
Depreciation & Amortization
-â‚©5.8B
CAGR 3-Years
-29%
CAGR 5-Years
-140%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Depreciation & Amortization
-â‚©9.3B
CAGR 3-Years
-10%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Depreciation & Amortization
-â‚©8.4B
CAGR 3-Years
-10%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Depreciation & Amortization
-â‚©818.8m
CAGR 3-Years
N/A
CAGR 5-Years
-31%
CAGR 10-Years
N/A
No Stocks Found

ABL Bio Inc
Glance View

Market Cap
1.3T KRW
Industry
Biotechnology

ABL Bio, Inc. engages in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2018-12-19. The major products include anti-angiogenesis antibodies anti-tumor targeting antibodies, T cell engager bispecific antibodies (TCEs), dual immune cell targeting bispecific antibodies (DICs), novel immune cell targeting antibodies (NICs), brain disease dual antibodies, antibody-drug conjugates (ADCs) , among others.

Intrinsic Value
8 401.38 KRW
Overvaluation 69%
Intrinsic Value
Price
A

See Also

What is ABL Bio Inc's Depreciation & Amortization?
Depreciation & Amortization
-1.9B KRW

Based on the financial report for Jun 30, 2024, ABL Bio Inc's Depreciation & Amortization amounts to -1.9B KRW.

What is ABL Bio Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
-30%

Over the last year, the Depreciation & Amortization growth was 14%.

Back to Top